Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBy day three after your first Mounjaro injection, many people find the nausea that arrived earlier in the week is at or near its peak — then begins to ease. This is a pattern well-documented in clinical evidence: the NHS tirzepatide medicines page notes that gastrointestinal side effects are most common in the early days after starting or after a dose increase, and typically settle as your body adjusts. Mounjaro is a prescription-only medicine. Whether it is right for you depends on a clinical assessment by a prescriber, not a checklist.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scene: you administered your first 2.5 mg pen on Sunday evening, felt broadly fine on Monday, then woke on Tuesday with a rolling, low-grade nausea that has not quite gone away by Wednesday morning. For most people starting Mounjaro, day three sits inside a predictable window of discomfort that is uncomfortable but not dangerous.
The mechanism behind this is well understood. Tirzepatide slows gastric emptying, food stays in your stomach longer than usual. Your gut is adjusting to a hormone signal it has not encountered before, and the result is often nausea, a reduced appetite, loose stools, or a general sense of having eaten too much even when you have not. Fatigue and mild headache sometimes accompany this.
A question our prescribers hear most weeks: "Is feeling this rough on day three a sign that the medicine is working?" The honest answer is that the side effects and the therapeutic effect are related to the same mechanism, but they are not the same thing. Feeling sick does not confirm the medicine is working; it confirms your body is responding to a new drug. Most people find the worst of this resolves within a week of each dose. You can read a fuller picture of the broader side-effect profile on our guide to Mounjaro side effects.
Not everyone experiences this in the same order. Some people feel nothing until day two; others have their worst hour within a few hours of the injection itself. Day three tends to be notable because tirzepatide's subcutaneous absorption peaks roughly 24–72 hours after administration, meaning plasma levels are at or near their highest point in that 48–72-hour window after your injection.
That peak-concentration window is also why nausea, burping and digestive discomfort are often reported as worse on days two and three than on day one. If your experience was milder on the first day, that is not unusual, and our page on what to expect from Mounjaro side effects on day one explains the earlier part of that curve, while the day-two picture covers the middle ground.
Eating small amounts of plain, low-fat food tends to be easier than large meals; fatty or rich food moves through the stomach more slowly still, which can intensify nausea when gastric emptying is already slowed. Alcohol is worth avoiding in the first few days. Sipping water consistently matters more than forcing meals, if you are keeping fluids down, you are doing the most important thing.
Persistent burping can feel disproportionately intrusive relative to its medical significance; there is more detail on why it happens and how to manage it on our page on burping with Mounjaro.
Most day-three side effects are self-limiting. These are the signals that are not.
Seek urgent medical help (call 999 or go to A&E) if you develop severe, persistent stomach pain that radiates to your back, with or without vomiting. This can indicate acute pancreatitis, which the MHRA identified as a known but infrequent risk in a Drug Safety Update published in January 2026. It is rare, but it is serious.
Also seek prompt medical attention for signs of significant dehydration, dizziness when you stand, inability to keep any fluid down, or very dark urine. Persistent vomiting combined with an inability to drink is not something to manage at home with ginger biscuits. Contact your prescriber or, if you cannot reach them, NHS 111.
A severe allergic reaction (swelling of the face, throat or tongue; difficulty breathing; a widespread rash) requires emergency care immediately. This is not a known common reaction to tirzepatide, but it is a known possibility with any injectable medicine.
If you are a nume patient and something feels wrong, our aftercare team is available seven days a week, you can reach us via the contact page. If you are not yet a patient but want to understand more about how Mounjaro works before starting, our Mounjaro overview page covers the full clinical picture.
There is no medically proven anti-nausea protocol specific to tirzepatide, but there is practical guidance drawn from how GLP-1 medicines behave generally. Eat small, plain portions: toast, plain rice, boiled potato, crackers. Avoid lying down immediately after eating. Stay upright for at least thirty minutes after a meal. Cold or room-temperature drinks often sit better than hot ones.
Timing your injection also matters in ways that become clear with experience. Many people find that injecting on a Friday evening means the worst of the day-two and day-three effects fall on the weekend, when the practical burden of feeling below par is lower. That said, if you want to understand what the first hours after an injection can feel like before committing to a schedule, our overview of tirzepatide day 1 side effects gives a useful reference point for how that initial window tends to unfold.
If day three feels very difficult, document what you experienced, when it started, what helped, whether anything specific made it worse. That information is useful for your prescriber when the question of dose titration comes up. The consultation process at nume includes a clinical review before any dose change, and your experience in that first week is a genuine part of the clinical picture, not just background noise.
Our prescribers discuss side effects and suitability in detail during the consultation, it is part of every assessment, not an afterthought. If you are considering starting treatment, a free consultation is the right first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.